NEW YORK (GenomeWeb) – Veracyte said on Thursday it has amended a loan agreement with Silicon Valley Bank originally forged in June 2013.

Under the terms of the amendment, Veracyte can borrow up to $15 million in three tranches, each tranche not exceeding $5 million. The company borrowed $5 million from the first tranche this week to repay in full the initial $5 million loan drawn in June 2013, the San Francisco-based developer of gene expression-based diagnostic tests said in a document filed with the US Securities and Exchange Commission. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.